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Abstract
The last few years have seen tremendous growth in human microbiome research, with a particular focus on the
links to both mental and physical health and disease. Medical and experimental settings provide initial sources of
information about these links, but individual studies produce disconnected pieces of knowledge bounded in
context by the perspective of expert researchers reading full-text publications. Building a knowledge base (KB)
consolidating these disconnected pieces is an essential first step to democratize and accelerate the process of
accessing the collective discoveries of human disease connections to the human microbiome. In this article, we
survey the existing tools and development efforts that have been produced to capture portions of the information
needed to construct a KB of all known human microbiome-disease associations and highlight the need for
additional innovations in natural language processing (NLP), text mining, taxonomic representations, and field-wide
vocabulary standardization in human microbiome research. Addressing these challenges will enable the
construction of KBs that help identify new insights amenable to experimental validation and potentially clinical
decision support.
Keywords: Natural language processing, Knowledge base, Microbes, Disease, Human, Model organisms,
Microbiome, Microbiome dynamics
Introduction
The rapid decline in the cost of DNA sequencing,
coupled with improved computational tools for inter-
preting DNA sequence data, has enabled microbes,
humans, and other hosts to be genetically characterized
at an unprecedented scale. High-throughput 16S rRNA
gene sequencing and more recently shotgun metage-
nomic sequencing technologies now provide a means of
efficiently identifying, classifying, and correlating micro-
biota with their environment [1–3]. Many new insights
have been revealed by these methods, demonstrating
that bacteria and other microbes such as archaea, yeasts,
protists, and viruses play an important role in shaping
human health and diseases [4–6]. These associations go
beyond links between the pathogens that individually
cause infectious diseases and include complex effects of
the whole human microbiome on a range of different
phenotypes. Accordingly, many laboratories have sought
to determine the state of the “normal” human micro-
biome, especially in the gut, and characterize uncommon
states as dysbiosis, presumed to be associated with both
innate and lifestyle diseases [1, 7–9]. This has led to an
exponential increase in the number of medical and ex-
perimental findings reported in publications linking mi-
crobes, including bacteria, to human diseases (Fig. 1).
Understanding and drawing insight from this literature
to establish human microbiome-disease associations for
hypothesis confirmation and generation will be critical
for scientific discovery going forward, but manually ab-
sorbing, interpreting, and curating the rapidly growing
volumes of texts is beyond the scope of any individual.
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The issue can be addressed with computer algorithms,
such as natural language processing (NLP) and subsequent
text mining techniques, to process existing repositories of
text including abstracts from PubMed (https://www.ncbi.
nlm.nih.gov/pubmed), full-text articles in PubMed Central
(https://www.ncbi.nlm.nih.gov/pmc/), and topic-specific
data repositories to extract and organize human micro-
biome-disease associations into a digestible form in
knowledge bases.
A knowledge base (KB) is a large-scale structured re-
pository of entities and relationships between them. One
of the most successful biomedical KBs is the GWAS
Catalog [10], containing entities of human genotypes
and phenotypes and their relationships—whether a stat-
istical association was observed between them in a pub-
lished genome-wide association study (GWAS). The
GWAS Catalog has become an essential resource for
genetic researchers and clinicians to prioritize candidate
loci and assess disease risk. The knowledge in that KB
would be inaccessible otherwise without its users spend-
ing substantial efforts undertaking systemic reviews of
the literature.
In a KB of human microbiome-disease associations, en-
tities may include at least microbial organisms and disease/
health conditions, while relationships between them may
include promotion, inhibition, causation, correlation, and
other types of associations. The huge volume of research
literature is one of the largest information sources contain-
ing these entities and relationships, which are frequently,
but not exclusively, built on experimental data deposited in
repositories such as the European Bioinformatics Institute’s
European Nucleotide Archive, the Joint Genome Institute’s
Genomes Online Database, and the National Center for
Biotechnology Information’s (NCBI) Sequence Read Arch-
ive. While these resources theoretically enable researchers
to gain access to new discoveries through meta-analyses of
16S and whole-metagenomic sequencing data that combine
information from many projects, in practice, this is infeas-
ible as metagenomes are routinely provided without suffi-
cient sample, preparation, and processing metadata to
determine the conclusions reached by the researchers who
designed the experiments, and for large data sets can fur-
ther be computationally infeasible. While new platforms
such as Qiita [11] will help to make this task more achiev-
able in the future, extracting results directly from publica-
tions into a KB derived from publications bypasses this
effort and provides a way to obtain information when a
pure computational task is infeasible. Furthermore, this
process leverages the insights provided by the researchers
who designed the experiments and generated the raw data
and includes almost all known high-quality, peer-reviewed
study results that are available rather than limiting insight
to studies where public sequencing data is available.
A major challenge to constructing a KB from the re-
search literature is that these research articles and re-
ports are written for human comprehension. Large-scale
extraction of the information will require computerized
NLP and text mining techniques to automate the
process, thereby allowing the construction of a know-
ledge base to be sufficiently large and useful. NLP and
text mining have largely matured in the general domains
with [12–14] as prominent examples. These advances
may potentially be translated into the use for human
microbiome research and represent a promising avenue
for the collection, curation, and normalization of human
microbiome knowledge from the relevant literature.
Ideally, such KBs should contain all known human
microbiome-disease associations from the research litera-
ture. However, many challenges must be addressed. Some
of these challenges are generally applicable to any KB
Fig. 1 The rate of publications linking bacteria to human disease in PubMed. The chart displays the yearly count of PubMed abstracts matching
human disease with microbes using the query (human AND disease) AND (microbiome OR microbiology OR microbes OR bacteria OR microbiota
OR fungi OR virus). While the rise in publications began several decades ago, the last decade has featured a rapid increase in the number of
publications spurred on by reductions in sequencing technologies and increased interest in the microbiome
Badal et al. Microbiome           (2019) 7:129 Page 2 of 15
construction task while others are unique to the construc-
tion of human microbiome-disease association KBs. One
of the most difficult challenges is how to identify and
normalize various entities of interest (i.e., bacteria and dis-
ease) which depend on standardized nomenclature and
ontologies. Otherwise, the computer may not know that
“Porphyromonas gingivalis” are bacteria and may mistake
“P. gingivalis,” “Porphyromonas gingivalis,” and “Bacter-
oides gingivalis” for different bacteria. Since the proof of
germ theory ~ 150 years ago, conventions in naming,
cataloging, and organizing diseases, microbes, and their
properties have evolved considerably. Over the last two
decades, new expected and unexpected discoveries [15] in
human microbiome-disease associations have further
blurred the line between the microbial host worlds and
concepts of disease. For example, the statement “Helico-
bacter pylori-induced atrophic gastritis predisposes to gas-
tric adenocarcinoma …” [16] illustrates a condition stated
as a composite of bacteria and a disease and calls for
advanced NLP techniques to correctly capture.
Extracting association relationships between the hu-
man microbiome and diseases poses similar challenges
and adds unique complications to challenge state-of-the-
art NLP. For example, in the statement “Crohn’s disease
(CD) is associated with bacterial dysbiosis that fre-
quently includes colonization by adherent-invasive
Escherichia coli (AIEC)” [17], one can ascertain that the
microbe entity “adherent-invasive Escherichia coli” has a
“positive association” relation with the disease entity
“Crohn’s disease” (Fig. 2a). There are numerous potential
association types that can be captured between the
human microbiome and diseases. It is important to
faithfully represent these associations with a well-defined
and comprehensive classification for KBs to be useful.
This article reviews current efforts of constructing KBs
of human microbiome-disease associations from the hu-
man microbiome literature, focusing on the areas for im-
provement in quality and validation and the associated
challenges. Yandell and Majoros [18] provided an over-
view of the biomedical NLP techniques enabling a simi-
lar effort in genomics, where the key drivers are
relations between genes, their sequences, and multitude
of text fragments available across repositories of biomed-
ical literature. The techniques reviewed may potentially
be reused and extended here. We further suggest poten-
tial solutions to overcome these challenges including
Fig. 2 a An example free-text snippet in a publication where an association between a bacterium and a disease is stated and can be
systematically extracted by NLP and text mining techniques to construct a knowledge base. b An overview of the essential steps of text mining
the literature for the construction of a knowledge base of human microbiome-disease associations
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both technical approaches and community efforts to ad-
dress the pressing needs of assembling and organizing
human microbiome-disease association knowledge.
Existing knowledge bases of human microbiome-
disease associations
Essentials of knowledge base construction
KBs of human microbiome-disease associations must at
least contain two essential entity types: microbes (most
frequently bacteria) and diseases. Microbes are organized
under a hierarchical taxonomy (kingdom, phylum, class,
etc.) of which usually lower levels (i.e., genus, species,
and subspecies/strains) are predominantly referred to in
the free text. The steps to obtain these relationships
usually include (Fig, 2b) the following:
– Entity extraction, in which mentions of microbes
and diseases are identified
– Entity normalization, in which extracted entity
mentions are mapped to canonical identifiers (e.g.,
“CD” is mapped to “Crohn’s disease”)
– Relation extraction, in which the context of pairs of
mentions is used to determine if a distinct
relationship exists between the entities
Common approaches employ either pipeline (sequen-
tial) or joint (parallel) modeling of these three tasks. In
addition, methods of verifying the validity and utility of
the extracted results populated into the KB are necessary
for the KB to be trustworthy and useful. More rigorous
verification should involve integration of primary experi-
mental data, e.g., metagenomic or metabolomic profiling
of microbial communities associated with host diseases.
Review of existing knowledge bases of human
microbiome-disease associations
Remarkably, only four KBs that capture human micro-
biome-disease associations have been published, all in
the last 2 years, with each limited in utility and the scope
of the corpora used in their creation.
In 2017, Ma et al. [19] created a KB to capture the rela-
tionships between microbes and entities including dis-
eases, genes, drugs, chemical fragments, and symptoms
from a limited set of 61 publications. Few specific meth-
odological details were reported beyond brief mentions of
text mining and manual curation. This KB captured 483
directional (increase/decrease) microbe-disease associa-
tions between 39 human diseases and 292 microbes. To
give a level of confidence in the validity of the extracted
relationships, the associations were assigned a weighted
score based on the number of publications supporting an
association. The score incorporates a Log(N/nj) term,
where N is the total number of diseases (here 39) and nj is
the number of diseases that are associated with microbe j.
While a good first step, the number of microbes are orders
of magnitude below the number in use in the microbiome
research literature (~ 19,717, as of 2017 [20]), limiting the
utility of this KB for the community.
In 2018, Song et al. [21] captured the relationships be-
tween diseases (hepatitis, conjunctivitis etc.), biomarkers
(Prolactin, apoa-I, etc.), microorganisms (Vibrio, Sal-
monella, etc.), and host organs (lung, liver, etc.) using a
correlation analysis on PubMed articles related to a pre-
defined set of 18 diseases and 21 biomarkers. Disease,
microorganism, and biomarker terms were expressed as
word embeddings [22] using canonical correlation ana-
lysis (CCA) [23], which is a statistical method for dimen-
sionality reduction. To validate the extracted relations,
they assessed the degree of co-occurrence using the
square root of the product of the number of publications
with each disease and the number of publications with
each marker appearing in their titles using the top 20
Google Scholar results from searching extracted pairs.
They reported that 85% of highly correlated pairs
appeared in these top results from Google Scholar, but
only 15% of weakly correlated pairs appeared. However,
this study is limited in the scope of diseases and
microbes considered, as well as in the methods used to
validate their associations.
Also in 2018, Janssens et al. [24] published the data-
base Disbiome which links diseases classified using the
Medical Dictionary for Regulatory Activities (MedDRA)
system with microbes normalized using NCBI and
SILVA taxonomies [24]. Disbiome also provides both
direction and context for the associations, including in-
formation on how the microbes were identified [24] and
providing answers to a survey of 16 questions that at-
tempt to capture the quality of the reported associations.
While Disbiome represents the largest and most com-
prehensive effort to date, covering nearly 200 diseases
and ~ 800 microbes, it was based on manually assembled
full-text publications associated with just 500 abstracts.
Such an effort is not sustainable or scalable given the
rapid pace of publication in this field as highlighted
above and in Fig. 1. However, their effort does provide a
solid framework for what kinds of information and
standards a high-quality KB should present to users.
Most recently, in January 2019, Noronha et al. published
the Virtual Metabolic Human (VMH) database, an exten-
sively curated interdisciplinary database with multiple
linked resources such as human metabolism, gut micro-
biome, disease, nutrition, and ReconMaps [25]. This data-
base hosts details of metabolic pathways in human and
gut microbes to enable visualization, investigation, and
nutrition design. Cross-reference to other resources out-
side of this database such as BIGG [26], Biocyc [27],
KEGG [28, 29], UniProt [30], etc. makes VMH easy to
navigate and query [25]. VMH uses ReconMaps [31] to
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account for reactions occurring in organelle and the hu-
man metabolic reactions occurring in the cytosol and the
extracellular space. While this effort will no doubt be a
great resource for the field, it prioritizes depth over
breadth, focusing on just 255 Mendelian diseases linked to
the metabolic genes and reactions in the same catalog and
667 species with manually curated genome-scale meta-
bolic reconstructions. This limited scope does not ad-
equately capture the large number of microbe-disease
combinations reported in the literature.
Although the four KBs that we surveyed above address
microbe-disease associations, they are quite different in
their intents and purposes. Ma et al. [19] illustrate the
types of consistencies that are exhibited by relationships
within the database. Song et al. [21], not surprisingly,
demonstrate that disease microbe co-mentions in scien-
tific publications imply the actual correlation between the
two. Janssens et al. [24] bring about formal rigor in the
identification of disease and microbial entities using spe-
cific ontologies. Virtual Metabolic Human [25] is designed
as an exploration tool.
We searched the most recent publications on biomed-
ical KBs, but to the best of our efforts, no new KB specific-
ally developed to provide associations of human
microbiome and diseases was found. The closest related
ones among them were Editome Disease Knowledgebase,
a database for RNA editome and disease associations that
may help in understanding RNA editing machinery and
thereby molecular mechanisms affecting diseases [32], and
gcMeta, a data repository for archiving and publishing hu-
man and environmental microbiome samples integrated
with web-based data analysis and workflow tools [33]. No
information of the associations between the microbiome
samples and diseases is provided explicitly.
As these publications represent the known work on
end-to-end KB construction for human microbiome-dis-
ease associations, there is much room for improvement.
In particular, there is a pressing need for new innovations
to enable the automatic construction of a KB of human
microbiome-disease associations.
Extraction and normalization of human
microbiome disease entities
Entity extraction, normalization, and relation extraction
have seen rapid maturation in the general text domain
[12–14], but there are still major challenges which need
to be addressed in the biomedical domain as a whole
and human microbiome-disease association in particular.
Extraction and normalization of microbe and disease
names begin with the creation of standard taxonomies
that capture the canonical entities which the community
has agreed to use. Standards for naming entities and for
modifying the taxonomy must be in place as well in
order to maintain consistency over time [20]. In addition
to a standard taxonomy, there is a need for large-scale
labeled datasets in order to provide wide-scoped ground
truth data for training and testing methods. Table 1
gives an overview of the existing datasets of species and
disease mentions that could potentially be used in creat-
ing these taxonomies. The complexity of each of these
tasks depends on the domain of discourse and the type
of entities, hence requiring a separate discussion of each.
Microbe extraction and normalization
Methods for performing the extraction and normalization
on microbial entities are presently limited by several fea-
tures shared with general NLP and text mining tasks as
well as several specific to the field. General challenges in
Table 1 Existing datasets for disease- and species-related entities. Note that there are only two datasets which contain both
diseases and species (miRNA and variome). In addition, species-level datasets are not specific to the human microbiome, so there is
a need to create datasets curated for human microbiota
Dataset Entity type No. of annotations No. of unique annotations
CDR [34] Disease 12,694 3459
Variome [35] Disease 6025 629
miRNA [36] Disease 2123 671
NCBI Disease [37] Disease 6881 2129
Arizona Disease [38] Disease 3206 1188
SCAI [39] Disease 2226 1048
CellFinder [40] Species 435 51
Variome [35] Species 182 8
miRNA [36] Species 726 47
S800 [41] Species 3646 1564
LocText [42] Species 276 39
Linneaus [43] Species 4077 419
BioNLP-ST 16 [43] Species 619 277
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NLP include recognizing mentions of entities of interest
and normalizing those entities to canonical names. In the
task of extracting microbial names, there is a paucity of ef-
fective tools targeted at recognizing their pattern of ap-
pearance, usage, and inherent hierarchical structure.
Development of these tools is hampered by a lack of well-
curated and labeled training examples, and a lack of a
stable, defined, and controlled list of microbial names and
synonyms.
Limitations of tools for microbial entity extraction
Microbial extraction tools generally use shallow parsing
with feature engineering (i.e., conditional random field
(CRF) [44–47]), and only recently with deep learning
[48, 49]. In fact, though these systems attempt to per-
form microbial, specifically bacterial, entity extraction,
the tools are designed to solve the general task of bio-
medical named entity recognition (NER) as opposed to
developing models specifically designed for microbial ex-
traction. Siu et al. [47] present a fast method for bio-
medical NER using character trigram features to
perform rapid lookup in the Unified Medical Language
System (UMLS) [50]. Habibi et al. [48] propose to use a
bidirectional Long short-term memory (LSTM) network-
and CRF-based model [51] for the general task of bio-
medical NER and obtain good results across entity types
(disease, species, chemical names, etc.). In addition, Li et
al. [52] propose a deep learning model which learns bac-
terial name recognition jointly with bacteria-habitat rela-
tion extraction. While useful for general species
recognition, these models focus on the entities not
specific to the human microbiome.
Limitations of annotated corpora of microbial entities
Obtaining ground truth data for microbial names is
challenging due to the requirement of human expertise.
As such, there is a lack of annotation tools, as well as
annotators, to mark all of the microbial names from do-
main to subspecies level. Consequently, existing datasets
with microbial entity annotations are sparse, containing
only several hundred to a few thousand annotations and
even fewer unique annotations (Table 1). In addition,
these datasets contain microbes at varying levels of taxo-
nomic resolution (e.g., phyla, genus, species, strain)
across a broad spectrum of life and are not human
microbiome specific. For example, the BioNLP Shared
Task 2016 dataset [53], which contains mentions of bac-
teria, geographical places, and habitat from PubMed
abstracts [54], contains many species related to plants
and archaea, not reflecting the domain of human
microbiota. This motivates the development of human
microbiome-related annotation tools along the same
lines as PubTator [55] as well as methods for encour-
aging active community engagement in providing new
ground truth annotations. Such tools should also enable
users to normalize microbial names as there exists no
single standard taxonomy for microbes.
Limitations of existing microbial catalogs and taxonomies
Once a microbe mention is identified and extracted
from a text, the mention must be linked to a microbe
entity defined by a standardized taxonomy for entity
normalization. In the domain of microbial naming, the
usage of multiple, sometimes competing, and incomplete
catalogs and taxonomies limits the ease of automatic en-
tity normalization, as well as manual collection, curation,
and normalization of information from the microbiome
literature. Prominent microbiome resources [56] such as
Bergey’s Manual of Systematic Bacteriology [57], Open
Tree of life Taxonomy (OTT) [58], SILVA [59], RDP
[60], Greengenes [61], and NCBI [54] differ in structure,
organization, maintenance, and scope. This is the result
largely of the methods of construction, i.e., manual or
automated curation, choice or presence of phylogenetic
trees, variation in sequence composition, and intended
use of each [62]. The subsequent reliance on these re-
sources created compounding divergence of information
classification in the KBs previously highlighted.
Disbiome [24] linked the microbes to NCBI and
SILVA taxonomy. Virtual Metabolic Human [25] linked
microbes to external links such as NCBI taxonomy,
KBASE [63], Uniprot [30], The European Nucleotide
Archive (ENA) [64], Ensembl Bacteria [65], IMG [66],
MicrobeWiki [67], and Genomes Online Database [68].
Ma et al. [19] manually curated microorganisms at the
genus level. To help overcome these issues, in 1997, Jean
P. Euzéby created the List of Prokaryotic Names with
Standing in the Nomenclature (LPSN) now maintained
and updated by Parte [20]. LPSN lists the names of pro-
karyotes from the International Journal of Systematic
Bacteriology/International Journal of Systematic and
Evolutionary Microbiology (IJSB/IJSEM) and attempts to
provide the most up-to-date set of prokaryotic names
while tracking the changes to names over time. The reli-
ance of the field on a small collection of individuals,
largely volunteer, efforts to ensure that microbial names,
synonyms, and evolutions in conventions are captured
and cataloged further provides motivation for the auto-
mated construction of KBs in the field of human micro-
biome research.
Disease extraction and normalization
The task of extracting and normalizing human disease
names faces many similar challenges as microbial extrac-
tion and normalization. More tools exist for disease en-
tity recognition and extraction, but obtaining granular
information and normalization remain key challenges,
exacerbated by a surprisingly small set of annotated
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corpora. Progress is further inhibited by the existence
and common usage of multiple, domain-specific taxon-
omies and ontologies for organizing disease names.
Limitations of tools for disease entity extraction and
normalization
There are several systems that use the datasets listed in
Table 1 to identify and then normalize disease mentions
in text while a small number of tools have been deve-
loped for joint disease extraction and normalization.
DNorm [69] uses machine learning in conjunction
with the MEDIC vocabulary. Disease mentions are lo-
cated using BANNER [45] which is an entity recognition
system based on a CRF. Text mentions of diseases are
then represented using term frequency-inverse docu-
ment frequency (TF-IDF) [70, 71] vectors for
normalization. The names are normalized using pairwise
learning to rank which outputs a set of MEDIC [72]
concepts for extracted entities. DNorm achieved preci-
sion, recall, and F1-score of 0.8, 0.76, and 0.78, respect-
ively, on the NCBI disease corpus [37].
TaggerOne [46] was a follow-up to DNorm by the
same group. It utilizes semi-Markov models for joint
entity recognition and normalization and is trainable
for arbitrary entity types. Its performance on diseases
from the NCBI disease corpus for NER was 0.82 F1-
score, and its normalization F1-score was 0.8. Tagger-
One compares favorably with state of art and is con-
sidered a strong baseline for the disease recognition
and normalization task.
Our group recently developed the tool NormCo
[73], which applies deep learning to the tasks of hu-
man disease recognition and normalization. NormCo
uses a simple phrase embedding model with entity co-
herence that is achieved using a bidirectional gated re-
current unit (GRU) network in order to predict a
coherent set of diseases within a document. The
model shows strong improvements over TaggerOne
on the NCBI disease corpus and comparable perform-
ance on the CDR dataset.
Other groups have also been exploring deep learning
for NER and a multi-task learning framework for joint
disease NER and normalization. A bidirectional LSTM
network with a CRF output layer was presented in [48]
for the task of biomedical NER. They show a strong
performance across several datasets, indicating the po-
tential of deep learning for the biomedical domain
using the same neural network model as Habibi et al.
[48] as presented in Zhao et al. [74], which shows im-
provements across recognition and normalization. All
of the above methods rely on a source of well-curated
and annotated training data with known disease
names, synonyms, and hierarchies.
Limitations of existing human disease catalogs and
taxonomies
Annotated, consistent, and comprehensive datasets for
diseases, much like bacteria, are sparse, small-scale, and
variable. For example, the largest dataset of diseases
(CDR, see Table 1) contains only 3459 unique disease
annotations, covering only 1082 unique disease concepts,
whereas the Comparative Toxicogenomics Database
(CTD) MEDIC dictionary contains 11,885 unique
disease concepts (1082/11,885 = 9.1% coverage). In
addition, a standard taxonomy does not exist for resolv-
ing disease names from text, though several have been
attempted. One of the more popular taxonomies used
across a variety of datasets is the CTD MEDIC diction-
ary [72] which is used across multiple datasets [34, 37].
CTD maps diseases to their canonical Medical Subject
Headings (MeSH) or Online Mendelian Inheritance in
Man (OMIM) IDs. Such a taxonomy is useful for re-
search into knowledge base construction for human
microbiome-disease associations, as shown in the Virtual
Metabolic Human [25] which relied on 255 inborn er-
rors of metabolism reported in OMIM for diseases.
Other related disease taxonomies include UMLS [50],
which integrates and distributes key terminology, classi-
fication, and coding standards, including SNOMED-CT
[75], LOINC [76], RxNorm [77, 78], ICD-9 [79], ICD-10
[80], and many others.
These terminology systems were designed with dif-
ferent purposes and may not always serve the re-
searchers’ purposes. For example, ICD was designed
for statistical and reporting purposes, and as such, less
common diseases may be lumped into a broad cat-
egory, resulting in loss of information. In contrast,
SNOMED-CT was designed for patient care documen-
tation by clinicians and may better cover medical vo-
cabularies used in verbal clinical communications. For
example, ICD-10-CM diagnosis code E87.2 “Acidosis”
cannot be classified further while SNOMED-CT con-
tains at least three subclasses of acidosis: “metabolic
acidosis,” “respiratory acidosis,” and “lactic acidosis.”
SNOMED-CT clinical findings contain about 100K
unique codes while ICD-9-CM contains only 14K and
ICD-10-CM 68K. Among the 4 existing KBs, Janssens
et al. [24] relied on an entirely different classification
for their diseases using the Medical Dictionary for
Regulatory Activities (MedDRA) classification system,
highlighting the wide range of existing, inconsistent
disease resources. Virtual Metabolic Human [25] inte-
grates 21 external resources one of them being OMIM
for diseases.
UMLS attempts to integrate these vocabularies by
identifying subsets, mappings, and extensions and create
lexical and mapping software tools. Therefore, in
addition to identifying mentions of diseases through the
Badal et al. Microbiome           (2019) 7:129 Page 7 of 15
comprehensive lists of aliases and synonyms in UMLS, it
is also possible to take advantage of its 130 semantic en-
tity types (e.g., “abdominal pain” is an entity of symptoms
and signs, while “morphine” is a clinical drug) and 54 re-
lations (e.g., “abdominal pain” is a symptom at the body
part “abdomen”) for NLP to infer and extract disease
mentions. Nevertheless, these taxonomies are general,
containing entries for congenital diseases, disorders, and
infectious diseases which may not be of interest to the
community. Therefore, it may be necessary to curate a
standard taxonomy of diseases specific to human micro-
biome-disease research that takes into account the inter-
actions between microbes and their hosts.
Extraction and representation of microbe-disease
associations (relations)
Beyond entity extraction and normalization, it is necessary
to build systems which can identify, ideally directional
relations between entities of interest (i.e., microbes and dis-
eases). Association (relation) extraction is usually a two-step
process, requiring entity extraction at first. There are five
major techniques that are usually employed for association
extraction: (1) hand-crafted rules or slot grammars, (2)
bootstrapping methods or semi-supervised learning, (3) su-
pervised learning, (4) distant supervised learning, and (5)
unsupervised learning. The first two techniques vary on
how explicit the knowledge is coded, and the last three vary
on how much effort is required for training. The training
features themselves can be as simple as the presence of key-
words, distance between entities, or something more
complex such as a dependency parse tree.
The existing relation extraction approaches usually as-
sume that a finite fixed set of relation types is given for
NLP to assign the extracted relation to and that these re-
lations are binary, that is, they are one to one. However,
currently, no such set of association types for human
microbiome and diseases is even in existence. As a re-
sult, there is a need to categorize and define the associ-
ation types. We discuss the challenges involved in this
association representation task from both technical and
biological perspectives.
Extraction of microbe-disease associations
Limitations of tools for extracting microbe-disease
associations from the text
A simple approach to extract commonly occurring binary
relationships is by using rules such as co-occurrence [81].
Slot grammars, in which entities are assigned to slots
using template-based rules [82], allow for extracting rela-
tions of high order and complexity. Parse trees are widely
used tools in the matching process to decompose a sen-
tence into syntactic units, which can be used to deduce an
implicit association implied from a sentence [82]. An ad-
vantage of grammar and parse tree-based approaches is
that they do not depend on a large annotated corpus and
may achieve a good precision, that is, the extracted associ-
ations are mostly correct. Their weakness is that these
grammar rules and templates can hardly cover a wide var-
iety of expressions that authors may use to state an associ-
ation, resulting in a low recall, where too many stated
associations in an input text are missed.
Recently, deep learning approaches have been pro-
posed, for example by Verga et al. [83], who used a self-
attentive transformer network to jointly learn entity rec-
ognition and relation extraction. Li et al. [52] described
a neural network-based system to jointly perform entity
recognition and relation extraction simultaneously to ex-
tract bacteria-drug associations. Though these deep
learning approaches may generalize better to cover a
wide range of expressions than rule-based approaches,
their extraction performance results are still below 0.8 in
terms of precision, recall, and F-score and may still be
insufficient for high-quality KB construction. In general,
relation extraction is still a challenging open research
problem in all domains of NLP.
Also, existing works on relation extraction usually ex-
pect that the mention of a microbe in the proximity of a
mention of a disease is strongly suggestive of an associ-
ation. However, challenges may stem from anaphora and
resolution of disease mentions. For example, authors
may state that a certain bacterium exacerbates a symp-
tom for patients of a certain disease instead of stating
directly that the bacteria exacerbates that disease. This
issue is related to the challenge of how to define and
categorize a set of association relationships for KBs to
fully capture the nuance of the connections as under-
stood by human readers.
Limitations of knowledge graph completion
As the rapidly expanding body of knowledge about the
associations between the human microbiome and disease
shows no sign of decreasing with time, once this infor-
mation has been parsed from purely human-interpret-
able into a KB, it should be possible to infer new
associations from known associations. This computa-
tional task is known as knowledge graph completion [84]
and has produced some interesting results in domains
including protein-protein interactions [85–87]. The idea
is that when a sufficiently large number of entities and
the relationships between them are accumulated, we can
consider them as a knowledge graph with entities as the
nodes and relationships as the links in the graph. From
the graph, it may be possible to induce signature pat-
terns that can be used to accurately predict the presence
of a relationship between two entities. Once the signa-
ture patterns are induced, we can then interpolate new
relationships that are unknown between entities in the
graph. Knowledge graph completion may complement
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NLP and text mining to increase knowledge base cover-
age and reveal latent relationships which may be difficult
to extract from text.
Binary Matrix Completion MDA (BMCMDA) devel-
oped by Shi et al. [88] is a method that infers new mi-
crobe-disease associations from HMDAD developed by
Ma et al. [19]. Similar work includes KATZHMDA [89],
PRWHMDA [90], BiRWHMDA [91], and PBHMDA [92].
However, they share a common weakness that they have
been evaluated on limited training data from HMDAD
which provides a limited dataset that is far from sufficient
as the ground truth. A larger KB with a sufficient number
of reliable ground truth associations is necessary for a
rigorous comparison of these knowledge graph comple-
tion approaches.
Classification and representation of microbe-disease
associations
Similar to the need of standardized catalogs and taxon-
omies for entity extraction and normalization, associa-
tions in a KB also need to be standardized. This section
discusses the challenges of creating a standard to classify
and represent microbe-disease associations.
Challenges of creating a community-agreed classification
of microbe-disease associations
There are a wide variety of associations between a mi-
crobe and a disease which have been observed and re-
ported. A challenge is to classify these association
relations into a set of useful and well-defined categories of
association types. Intuitively, one may divide these associa-
tions into causation vs. correlation/inverse causation (e.g.,
reduced immunity resulting in bacterial growth) or neg-
ation of a previously reported relation. Potentially, we may
apply either a knowledge-based approach (e.g., [93]) or a
data-driven approach (e.g., [94]) to define and classify mi-
crobe-disease associations. As is the norm, Janssens et al.
[24], Song et al. [21], and Ma et al. [19] model microbe-
disease associations as qualitative directional (reduced vs.
elevated) relationships only. This limits their usability in
situations where disease progression may be associated
with microbial blooms and possible cyclical replacements
of communities of organisms. In a knowledge-based ap-
proach, we consider the mechanisms of how microbes
interact with their hosts to create phenotypes and derive
association types based on the underlying mechanisms. In
a data-driven approach, we may extract a large collection
of snippets from the literature where microbes and dis-
eases are co-mentioned and cluster these snippets into se-
mantically similar types to create a classification of
associations. A hybrid approach can also be applied, but
the resulting classification should be presented to the re-
search community to request for feedback to ensure the
quality and coverage.
Challenges of representing stability and validity of
associations
A major shortcoming of the existing approaches to en-
tity and relation extraction for KB construction in NLP
for general domains is that they usually assume that re-
lations between entities are stable and permanent. How-
ever, human microbiome diversity and composition (i.e.,
species count and relative percentages) are not stable. In
reality, human microbe populations can fluctuate tre-
mendously, even over the course of a few hours, and
may be influenced by factors including time since last
meal, fasting, and passing of stool [95–97]. Variations in
internal environment [4] due to diet [98–100], antibi-
otics, and host immunity all play an important role in
shaping the gut microbiome [101, 102], and host genet-
ics may influence both the microbiome and the progres-
sion of diseases such as inflammatory bowel disease
[100]. Other factors, including microbial products such
as lipopolysaccharides (LPS) and trimethylamine N-
oxide (TMAO) may be important to capture when relat-
ing the presence or absence of microbes with specific
diseases [100]. How to faithfully represent such condi-
tional associations will need to be addressed to produce
a high-quality KB with actionable information for
informing human disease stratification.
A potential solution is to use dynamic models to
model human microbiome dynamics to complement
static association relations asserted in a human micro-
biome-disease KB. A dynamic model captures and ex-
presses the interaction between microbes and human
disease with mathematical models such as ordinary dif-
ferential equations and Monte-Carlo methods as they
can more precisely describe the quantitative and dy-
namic aspects of microbial associations [93]. Exactly
how to construct a KB that represents dynamic associa-
tions is still an open research problem.
Integration of knowledge base and experimental
data
Verifying the validity of KBs using experimental data
We can use experimental data to verify and validate the
data extracted by NLP. Typical NLP and text mining
tasks rely almost exclusively on manually annotated data
as the ground truth to assess their accuracy and per-
formance, but the tight link between microbiome data
and human microbiome-disease interactions provides
opportunities for exploiting experimental data as a
source for these assessments as well as for generating
new hypotheses. For example, we may use extraction
tools and automated retrieval scripts to identify the con-
nections of the data and analysis with EBI/ENA or Qiita
[11] study identifiers and GitHub repositories or Qiime2
[94] objects with provenance. The structured text (i.e.,
tables and nested lists) of the per-sample metadata could
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then be used to verify the accuracy of disease mentions
and normalization. Once the NLP-based approach is
well-trained, the approach can be applied to the entire
corpus of publications to extract knowledge that is not
attainable in Qiita.
Likewise, reprocessing the experimental data with the
provided scripts could confirm tagged microbe-disease as-
sociation relationships as reported in the manuscript. Fur-
thermore, by reprocessing the data using the latest best
practices in microbiome analyses using tools like Qiita, it
may be possible to identify the discrepancies between the
reported and inferred associations based on the total hu-
man microbiome disease corpora. This would provide an
objective, data-driven curation of associations while pro-
viding a metric of confidence in assessing the authors’ in-
terpretations of the data presented in their articles.
We note that while the metadata available in Qiita covers
the bacteria and related disease entities, the relationship as-
sociating them and more findings and insights that can be
derived from publications will not be available from Qiita.
Demonstrating the utility and expanding KBs with
experimental data
A KB that enables an informative, insightful overview of
all the published articles for a given field would not only
allow users to stay current with the state-of-art but ac-
celerates several universal tasks in research, including
knowledge consolidation, new hypothesis generation,
and identification of conflicting findings and biased data.
We outline concrete examples of the use of a KB that re-
positories of experimental data do not provide alone and
provide a worked example using the Disbiome know-
ledge base in this section.
Knowledge consolidation
A primary goal of a microbe-disease KB will be to con-
solidate lists of bacteria associated with the same disease
in independent studies. As many bacterial names evolve
and undergo reclassification, microbe-disease association
KB can absorb such changes with minimal effort while
allowing the continuity of associations to be maintained.
A KB leveraging NLP to extract findings and insights
from the publications will enable a rapid evaluation and
prioritization of information that is impossible to achieve
by simply scanning related publications or re-analyzing
raw data scattered in multiple sources with inconsistent
and variable metadata. The sheer amount and the
growth rate of the publications demand an automated
NLP approach.
Hypothesis generation
For KBs to have research or even diagnostic values, there
must be clear paths to link primary analyses of human
microbiome samples with information stored in the KB.
As direct reference ranges for microbial populations can
be difficult to establish and validate, inferring disease as-
sociations directly from experimental data are unlikely
to succeed [103]. Instead, the KB may be used as a tool
to suggest additional orthogonal testing of a microbiome
sample, or the host donating the sample, to assist in the
characterization of the diseases or conditions present.
Over time, capturing primary experimental data through
automated retrieval as discussed above and appropriate
tagging of new primary experimental data used to query
the KB may enable the appropriate embedding of single
or multi-layer primary microbiome data as a component
of the KB. For example, metagenomic and metabolomic
analysis of a human microbiome sample could point to
abnormal or modified host or microbial biological path-
ways. The inferred de novo associations can be cross-
checked against patient symptoms or other data sources
that capture specific pathway-host and pathway-microbe
information. Indeed, there exist a large number of hu-
man-specific and microbe-specific databases that can be
explored for integration into a unified and minimally
cross-compatible KBs that capture information at the
DNA, RNA, transcriptome, protein, metabolic, and/or
structural levels [6, 104, 105].
Confirmation bias and contradiction
As a consequence of the knowledge consolidation inher-
ent in a KB construction, the likelihood of bias can be
examined by evaluating the proportion of associations
that consist of self-citations or citations among networks
of co-authors and collaborators.
In addition, the KB may readily expose biased informa-
tion in the form of contradictory/conflicting findings be-
tween publications that deserve further investigation.
For example, microbes shared across several etiologically
different diseases are candidates for investigation of con-
tamination or PCR bias, since it is unlikely for one or-
ganism to be a driver across so many different diseases.
Sources of contradiction may include differential phys-
ical or statistical techniques for evaluating associations
between microbes and diseases, potential unaccounted
for variables, or spurious associations due to the use of
contaminated laboratory reagents. This latter concern is
best highlighted by the body of reports that PCR-based
16S rRNA gene sequencing and shotgun metagenomics
methods can be impacted by contamination of microbial
DNA during sample preparation due to molecular biol-
ogy grade water, PCR reagents, or DNA extraction kits.
Salter et al. reviewed various approaches to the problem
[106]. Eisenhofer et al. [107] highlighted the impact of
contamination, including contaminant DNA and cross-
contamination, on microbiome research in low microbial
biomass samples and recommended steps at different
stages of an experiment known as the “RIDE” checklist.
Badal et al. Microbiome           (2019) 7:129 Page 10 of 15
It is indeed feasible to match the microbe genera ex-
tracted by NLP from publications against the list of con-
taminated genera provided by Salter et al. [106] and
Eisenhofer et al [107], as well as the more recent reviews
to flag in the KB if a study may be driven by
contaminants.
Worked example using the Disbiome knowledge base
In order to illustrate the above points, we selected two
diseases with both overlapping and distinguishing clin-
ical and etiological features: type 1 diabetes (T1D) and
type 2 diabetes (T2D). Identifying common and diver-
gent microbial profiles within each disease and between
them could help researchers prioritize the avenues of re-
search for microbe-host-disease interactions.
We began by selecting the list of organisms detected
in “feces” from annotated experiments relating to each
disease in Disbiome [24] and reduced this list to organ-
isms annotated in > 1 experiment within the diseases or
across the diseases (Table 2). This consolidation of
knowledge enables us to quickly ascertain that of the 11
organism names annotated to be elevated in T1D, only 5
(the genera Bacteroides, Blautia, and Veillonella and the
species Bacteroides ovatus and Streptococcus mitis) are
annotated from multiple experiments. We can further
see an evident contraction that 5 of the remaining 6 are
also annotated as being reduced in T1D. Conversely, of
the 12 organisms annotated as reduced in T1D, only 4
(the genera Acidaminococcus, Dialister, Haemophilus,
and Lachnospira) have multiple supporting annotations
while 5 have contradictory findings.
However, a quick comparison of the list in Eisenhofer
et al. [107] reveals that one of the contradictory
organisms, Prevotella, is a common contaminant, and
likewise, four additional elevated microbes and two add-
itional reduced microbes are also contaminants. After
excluding the contaminants, the remaining bacteria with
contradictory associations within a disease are excellent
candidates for meta-analysis, identifying the difference in
initial conditions, experimental methods, and/or bio-
informatics and statistical techniques. Tools such as
Qiita [11] and redbiom [108] may soon enable these
analyses, though often incomplete or insufficient sam-
pling, processing, and missing analysis metadata still
make resolution of the contradiction challenging.
From the reduced list of microbes with non-contra-
dictory evidence for their direction of association, a var-
iety of ecological and etiological hypotheses can then be
surmised by looking for common metabolic pathways,
reports of competition between these groups, or impacts
from medications or diet. Completing a similar compari-
son within T2D reveals only two organisms, Blautia
coccoides and Faecalibacterium prausnitzii, that have
multiple experimental annotations in the same direction
(reduced). Intriguingly, these same organisms are re-
ported to be associated with a reduced presence in T1D,
albeit in a single experiment. This encourages the anno-
tation of additional T1D and T2D reports to confirm
this common association between the diseases and
thereafter examine whether the reduction could be
caused by the shared clinical features or perhaps causal,
or evidence of causal impacts, in progression toward
each disease.
While this example demonstrates the power of even a
relatively small, manually curated, and annotated KB,
implementation of the recommendations laid out in this
Table 2 Findings from the Disbiome KB [24] for type 1 and type 2 diabetes with organisms annotated as elevated (+) or reduced
(−) in “feces.” The counts represent the number of published experiments corroborating the findings as annotated in Disbiome
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review could enable even more potent knowledge con-
solidation, hypothesis generation, and bias detection. In-
deed, within the expanded list of microbe names
associated with each disease in Disbiome [24] used to
create Table 2, there are several non-approved and re-
classified bacterial names (Additional file 1: Table S1).
Furthermore, by elaborating the full taxonomy of each
name, we were able to uncover additional patterns of
commonalities between T1D and T2D, as well as further
contradictions (Additional file 1: Tables S2 and S3).
Many of the contradictory and share bacteria were un-
surprisingly reported to be contaminants as summarized
in Eisenhofer et al.’s list [107]. All of these findings and
inferences were performed manually, but demonstrate
when an automated, robust, taxonomically aware, up-to-
date KB can potentially bring about.
Outlook and conclusions
We have reviewed an existing work on the automatic
construction of knowledge bases of human microbiome-
disease associations and identified essential technical
challenges of this task. Based on our review and study,
we summarize three key research thrusts that should be
prioritized to accelerate the development of useful
knowledge bases.
Create common controlled vocabularies for bacteria,
related entities, and associations
Common controlled vocabularies are essential to extract
and normalize the various entity types so that the re-
search community has a common yardstick to measure
progress and share resources. Additionally, controlled
vocabularies are important for the users of KBs. How-
ever, currently, commonly agreed vocabularies are miss-
ing, and many different ones have been used as reported
in the literature. Bacterial names are typically available
from LPSN [20] with detailed specification about their
taxonomy, where each taxonomic category is a single
word that allows for quick and easy lookup from a dic-
tionary or hash table. In contrast, a CTD-like database
[109] is available for diseases where a cursory examin-
ation is sufficient to realize disease names could be a
single word or phrases with several synonyms and de-
scriptions and proportionately many anaphoric refer-
ences complicating the task. Also, it is crucial to develop
a common classification of microbe-disease associations
that covers known types of associations and to develop
representations that capture dynamics of associations.
Create and share large annotated text corpora to serve as
the benchmark ground truth for the training and
evaluation of the developed approaches
Similarly, large annotated text corpora are missing. This is
a common issue shared by the whole biomedical NLP field
because annotating biomedical text requires specialized
expertise that is much more expensive than other NLP
domains such as sentiment analysis of restaurant reviews.
Though many semi-supervised and unsupervised machine
learning approaches are developed to reduce the need of
large volumes of annotated datasets for training machine
learning algorithms, there is always a need to evaluate and
compare the performance of NLP algorithms. Currently
available benchmark datasets are too small (see Table 1)
to reliably assess the performance when a system is ap-
plied to extract knowledge from, say, the entire set of
PubMed abstracts. Resources need to be invested in the
creation of such benchmarks as a community-based effort,
combining the input of both expert and more-novice users
to create a broadly relevant set of ground truth annota-
tions with normalized and standardized taxonomies. This
would further reduce the reliance on expert users for all
annotation tasks as expert knowledge should not be re-
quired to identify the direction of an association between
two domain-specific entities.
Translate the recent advances in natural language
processing from the general domain to various text
mining tasks essential to automatic knowledge base
construction in biomedicine
Primary techniques for entity extraction across various
domains include dictionary lookup, rule-based, and super-
vised learning using CRF and deep learning, with the best-
performing systems using hybrid approaches. State-of-the
art systems achieve adequate accuracies, recall, and F1-
scores for KB construction but require entity-specific imple-
mentation details. Advances in deep learning have enabled
rapid improvements in entity recognition and normalization
using a combination of BiLSTM and CRFs [48, 49, 110],
and while these methods have begun to be translated into
the biomedical domain, the rate of advancement in general
domain NLP continues to accelerate. It will be important to
investigate recent methods, especially pre-trained language
models [14, 111, 112], which have shown dramatic improve-
ments across language tasks, including entity recognition. Fi-
nally, relation extraction for microbes and diseases remains
an open research problem. Most relation extraction systems
rely on matching key terms and patterns in parse trees or
phrases with templates. Few systems use word embedding-
based deep learning approaches due to the lack of a large
training corpus. Potential solutions for mitigating this lack
of data include transfer learning [14], in which a model
trained on a large general domain corpus is fine-tuned on a
small corpus in the domain of interest, as well as multi-task
learning [46, 74].
Potential issues and limitations
There are some potential issues and limitations that a
KB derived from the literature may have that we need to
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be aware of when constructing a KB for human micro-
biome and disease associations. The KB will share the
bias of the published literature. One of the well-known
bias of the published literature is toward topics that are
well funded; therefore, microbes and diseases that are in-
tensively studied with rich funding will be covered more
than those otherwise. Paywalls may be another issue for
the construction of KBs but may be alleviated if pub-
lishers such as Elsevier and Springer Nature recognize
that KBs add values to their contents and are willing to
open text and data mining APIs to facilitate their sub-
scribers to mine their paywalled contents automatically.
Finally, eventually, the KB will need to cover non-Eng-
lish publications. For the moment, since NLP for lan-
guages other than English and machine translation are
progressing rapidly, KB construction approaches devel-
oped for mining English publications can potentially be
extended to other languages, though the amount of non-
English publications at the moment may not justify the
costs to include them. Moreover, non-English publica-
tions may already use Latin scientific names of bacteria
for which a bacteria name entity extractor designed for
English publications may still work with trivial changes.
In sum, the construction of a knowledge base of human
microbiome-disease associations will be critical due to the
rapidly expanding literature in the area, but the execution
of this construction comes with several key technical chal-
lenges. In this article, we have identified the primary chal-
lenges, discussed the state of the art for each associated
task, identified the limitations of current approaches and
resources, and made our proposals for moving toward a
fully realized KB of human microbiome-disease associa-
tions. It will be important going forward to identify spe-
cific entities of interest (both microbes and diseases),
develop standard taxonomies of these entities, and curate
relevant datasets in order to accelerate progress in this
area. It is our hope that this critical survey will motivate
the community to engage in more research on this im-
portant topic.
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